IL312274A - Compositions comprising ciprofloxacin and celecoxib - Google Patents

Compositions comprising ciprofloxacin and celecoxib

Info

Publication number
IL312274A
IL312274A IL312274A IL31227424A IL312274A IL 312274 A IL312274 A IL 312274A IL 312274 A IL312274 A IL 312274A IL 31227424 A IL31227424 A IL 31227424A IL 312274 A IL312274 A IL 312274A
Authority
IL
Israel
Prior art keywords
tablet according
ciprofloxacin
celecoxib
previous
tablet
Prior art date
Application number
IL312274A
Other languages
English (en)
Hebrew (he)
Inventor
Ben Noon Alon
Sterling Jeffrey
Yacoby-Zeevi Oron
Cohen Vered Sharon
Original Assignee
Neurosense Therapeutics Ltd
Ben Noon Alon
Sterling Jeffrey
Oron Yacoby Zeevi
Cohen Vered Sharon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosense Therapeutics Ltd, Ben Noon Alon, Sterling Jeffrey, Oron Yacoby Zeevi, Cohen Vered Sharon filed Critical Neurosense Therapeutics Ltd
Publication of IL312274A publication Critical patent/IL312274A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL312274A 2021-10-19 2022-10-18 Compositions comprising ciprofloxacin and celecoxib IL312274A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163257130P 2021-10-19 2021-10-19
PCT/IL2022/051096 WO2023067592A1 (en) 2021-10-19 2022-10-18 Compositions comprising ciprofloxacin and celecoxib

Publications (1)

Publication Number Publication Date
IL312274A true IL312274A (en) 2024-06-01

Family

ID=85982158

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312274A IL312274A (en) 2021-10-19 2022-10-18 Compositions comprising ciprofloxacin and celecoxib

Country Status (9)

Country Link
US (1) US12097185B2 (enExample)
EP (1) EP4419099A4 (enExample)
JP (1) JP7857044B2 (enExample)
KR (1) KR20240090519A (enExample)
CN (1) CN118369097A (enExample)
AU (1) AU2022370513B2 (enExample)
CA (1) CA3235348A1 (enExample)
IL (1) IL312274A (enExample)
WO (1) WO2023067592A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
EP3641820B1 (en) * 2017-06-20 2022-12-28 Neurosense Therapeutics Ltd. Compositions comprising an anti-inflammatory drug and a dicer activator for use in the treatment of neuronal diseases
US12527768B2 (en) * 2017-06-20 2026-01-20 Neurosense Therapeutics Ltd. Compositions comprising an anti-inflammatory drug and a dicer activator for use in the treatment of neuronal diseases

Also Published As

Publication number Publication date
US20230120880A1 (en) 2023-04-20
EP4419099A1 (en) 2024-08-28
US12097185B2 (en) 2024-09-24
CA3235348A1 (en) 2023-04-27
AU2022370513A1 (en) 2024-05-16
CN118369097A (zh) 2024-07-19
EP4419099A4 (en) 2025-09-24
AU2022370513B2 (en) 2025-09-25
KR20240090519A (ko) 2024-06-21
JP2024539116A (ja) 2024-10-28
JP7857044B2 (ja) 2026-05-12
WO2023067592A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
JP3276962B2 (ja) 安定な医薬組成物
JPH01100134A (ja) 徐放性製剤
JP2005538105A (ja) 水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法
UA109659C2 (xx) Фармацевтичні композиції, що містять 4-аміно-5-фтор-3-$6-(4-метилпіперазин-1-іл)-1h-бензімідазол-2-іл]-1h-хінолін-2-ону лактату моногідрат
HUP0203334A2 (hu) Közvetlen kompresszióval előállított polimer tabletta magok
JPH09500910A (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
TW201922230A (zh) 控釋製劑
EP2740471B1 (en) Oral pharmaceutical composition comprising dabigatran etexilate
TW202139977A (zh) 包括阿托伐他汀以及怡妥錠的雙層片劑及其製造方法
JPS5883618A (ja) ニトロフラントイン投与剤
JP5208729B2 (ja) 徐放性錠剤の製造方法
WO2017101858A1 (zh) 环苄普林之延释剂型
US5198228A (en) Direct dry compressible acetaminophen tablet
FI114610B (fi) Menetelmä beta-fenyylipropiofenonijohdannaisia sisältävien retardmikrotablettien valmistamiseksi
US5037658A (en) Direct dry compressible acetaminophen composition
TW201306881A (zh) 緩釋對乙醯胺基酚調配物
JP2022544167A (ja) ニトロキソリンを含む医薬組成物、ニトロキソリン経口固形錠剤、その調製方法、及びその使用
WO2004017938A2 (en) Nitrofurantoin controlled release dosage form
US5130140A (en) Method of making direct dry compressible acetaminophen composition
RU2024111884A (ru) Композиции, содержащие ципрофлоксакин и целекоксиб
WO2017093890A1 (en) Clobazam tablet formulation and process for its preparation
JPH08325142A (ja) ヨウ化イソプロパミド含有製剤
EP3052086A1 (en) Pharmaceutical composition comprising low dose active pharmaceutical ingredient and preparation thereof
EP1713452A2 (en) Sustained release pharmaceutical composition of indapamide
JP4884772B2 (ja) 経口徐放性錠剤